Novozymes A/S is a biotechnology based company. The Company researches, develops, produces, and sells enzymes for industrial use. Novozymes works within three main segments: the technical enzyme market, the food enzyme market, and the animal feed enzyme market. The Company has a worldwide distribution network, as well as operates sales and service centers online.
In India, the Pharmaceutical business of Novozymes A/S is focused on methods for enhancing the dewaterability of sludge with enzyme treatment, polypeptides having phospholipase C activity and polynucleotides encoding same, spore containing granule.
Novozymes A/S filed patent application numbered 2424/MUMNP/2013 that is titled A METHOD FOR PRODUCING COMPOSITION WITH SPRAY-DRIED LACTOBACILLUS STRAINS/CELLS. This Patent Application has been granted as as Patent number 316778.
The invention covers Biotechnology compound. This invention relates to spray-dried Lactobacillus strains and/ or Lactobacillus cells (lactic acid bacteria) and to the uses thereof, in particular for pharmaceutical and/ or dietary compositions for the treatment and prophylaxis of Helicobacter pylori infections in humans and animals.
During patent examination, the patent examiner raised objections under Section 3(d) of the Indian Patents Act that According to section 3 (d) of the Act, the mere discovery of a new form of a known substance which does not result in the enhancement of the known efficacy of that substance or the mere discovery of any new property or new use for a known substance or of the mere use of a known process, machine or apparatus unless such known process results in a new product or employs at least one new reactant, in the present application the said composition Lactobacillus (LB) composition for H. Pylori treatment and process where there is a combination of routine steps and selections of already known compound (LB) required for spray drying process.
As a response to the said objection, the applicant submitted that the degree of co-aggregation with Helicobacter pylori of spray-dried Lactobacillus cells is more than twice that of freshly cultured cells. Based on the examples and graphs in the figures mentioned, there is a technical advancement over the prior art.
Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter.
Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech).
Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.
